Anti-IL6R role in treatment of COVID-19-related ARDS.J Transl Med. 2020 04 14; 18(1):165.JT
Links
MeSH
Pub Type(s)
Editorial
Comment
Language
eng
PubMed ID
32290847
Citation
Buonaguro, Franco Maria, et al. "Anti-IL6R Role in Treatment of COVID-19-related ARDS." Journal of Translational Medicine, vol. 18, no. 1, 2020, p. 165.
Buonaguro FM, Puzanov I, Ascierto PA. Anti-IL6R role in treatment of COVID-19-related ARDS. J Transl Med. 2020;18(1):165.
Buonaguro, F. M., Puzanov, I., & Ascierto, P. A. (2020). Anti-IL6R role in treatment of COVID-19-related ARDS. Journal of Translational Medicine, 18(1), 165. https://doi.org/10.1186/s12967-020-02333-9
Buonaguro FM, Puzanov I, Ascierto PA. Anti-IL6R Role in Treatment of COVID-19-related ARDS. J Transl Med. 2020 04 14;18(1):165. PubMed PMID: 32290847.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Anti-IL6R role in treatment of COVID-19-related ARDS.
AU - Buonaguro,Franco Maria,
AU - Puzanov,Igor,
AU - Ascierto,Paolo Antonio,
Y1 - 2020/04/14/
PY - 2020/04/02/received
PY - 2020/04/08/accepted
PY - 2020/4/16/entrez
PY - 2020/4/16/pubmed
PY - 2020/4/18/medline
KW - ARDS
KW - COVID-19
KW - IL-6
KW - SARS-CoV-2
KW - Tocilizumab
SP - 165
EP - 165
JF - Journal of translational medicine
JO - J Transl Med
VL - 18
IS - 1
SN - 1479-5876
UR - https://www.unboundmedicine.com/medline/citation/32290847/Anti_IL6R_role_in_treatment_of_COVID_19_related_ARDS_
DB - PRIME
DP - Unbound Medicine
ER -